IL1B and COVID-19: By contrast, the dynamic of MIP-1β, IL-1β, MIP-1α and IFN-γ showed a different evolution pattern, with a significant increase at month 1 and/or 3 among patients with mild/moderate disease, compared to those with severe COVID-19.